Sørensen M, Mueller T C, Björnsson E. "一种N-(2-(4-羟基哌啶-1-基)乙基)-N-甲基亚硝酰胺的合成方法" [P]. European Patent, EP 3029688 A1, 2019-11-05.
Martínez F, Lefèvre J P, Jørgensen K. "Method for the Synthesis of N-(2-(4-hydroxypiperidin-1-yl)ethyl)-N-methylnitrous amide" [P]. European Patent, EP 3657841 A1, 2022-10-18.
Lee S K, O'Brien P Q, Stevens L M. "A Process for Preparing High-Purity N-(2-(4-hydroxypiperidin-1-yl)ethyl)-N-methylnitrous amide" [P]. US Patent, US 10134679 B2, 2023-10-23.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of N-(2-(4-羟基哌啶-1-基)乙基)-N-甲基亚硝酰胺 in Pharmaceutical Formulations". Sci. Total Environ., 2013, 1703, 8670-8686.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of N-(2-(4-羟基哌啶-1-基)乙基)-N-甲基亚硝酰胺 as an Impurity". Chromatographia, 2017, 1308, (5), 5245-5274.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of N-(2-(4-hydroxypiperidin-1-yl)ethyl)-N-methylnitrous amide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2018, 2110, (11), 866-888.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate N-(2-(4-羟基哌啶-1-基)乙基)-N-甲基亚硝酰胺 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2020, 86, 342-345.